Skip to main content

Table 3 Coagulation factor activity at the onset of coagulopathy (%)

From: Fatal acquired coagulation factor V deficiency after hepatectomy for advanced hepatocellular carcinoma as a possible immune checkpoint inhibitor-related adverse event: a case report

 

Dilution 1×

Dilution 4×

II

< 6

44.4

V

< 6

< 22.0

VII

< 6

< 22.8

VIII

64

166

IX

11

64

X

< 6

40

XI

< 1

13.7

XII

21

43.7

XII

87